Hepatic artery intervention combined with immune-targeted therapy is superior to sequential therapy in BCLC-C hepatocellular carcinoma

BACKGROUND: Hepatic artery intervention combined with immunotarget therapy exerts excellent disease control and prolongs survival. However, the arrangement of hepatic artery intervention and systemic therapy confuses clinical decisions. METHODS: A two-center, retrospective clinical study was approve...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Hanzhi, Jian, Yan, Wang, Meijian, Liu, Fangfang, Zhang, Qi, Peng, Zhiqiang, Cheng, Na, Zhang, Wenfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349705/
https://www.ncbi.nlm.nih.gov/pubmed/36454282
http://dx.doi.org/10.1007/s00432-022-04386-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349705/
https://www.ncbi.nlm.nih.gov/pubmed/36454282
http://dx.doi.org/10.1007/s00432-022-04386-3

Ejemplares similares